Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry R Pease

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 3, 2010
Retraction. Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DCLarry R Pease
Leukemia & Lymphoma|October 23, 2002
Malignant B cells and antigenic receptor: necessity or habit?Bocoljub Ciric, Larry R Pease
Nature Immunology|February 27, 2004
Having it both ways: MHC recognition in cis and transPaul J Leibson, Larry R Pease
Nature Protocols|April 21, 2007
Gene splicing and mutagenesis by PCR-driven overlap extensionKarin L Heckman, Larry R Pease
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2005
B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cellsSuresh Radhakrishnan, Esteban Celis, Larry R Pease
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2010
Retraction for Radhakrishnan et al., B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cellsSuresh Radhakrishnan, Esteban Celis, Larry R Pease
Neurology|April 8, 2009
Invited article: human natural autoantibodies in the treatment of neurologic diseaseMoses Rodriguez, Arthur E Warrington, Larry R Pease
Cancer Research|November 4, 2010
Retraction: CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
Cancer Research|March 12, 2009
CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
CSH Protocols|March 2, 2011
PCR Mutagenesis by Overlap Extension and Gene SOEAbbe N Vallejo, Robert J Pogulis, Larry R Pease
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 3, 2010
Retraction. Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DCLarry R Pease
Leukemia & Lymphoma|October 23, 2002
Malignant B cells and antigenic receptor: necessity or habit?Bocoljub Ciric, Larry R Pease
Nature Immunology|February 27, 2004
Having it both ways: MHC recognition in cis and transPaul J Leibson, Larry R Pease
Nature Protocols|April 21, 2007
Gene splicing and mutagenesis by PCR-driven overlap extensionKarin L Heckman, Larry R Pease
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2005
B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cellsSuresh Radhakrishnan, Esteban Celis, Larry R Pease
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2010
Retraction for Radhakrishnan et al., B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cellsSuresh Radhakrishnan, Esteban Celis, Larry R Pease
Neurology|April 8, 2009
Invited article: human natural autoantibodies in the treatment of neurologic diseaseMoses Rodriguez, Arthur E Warrington, Larry R Pease
Cancer Research|November 4, 2010
Retraction: CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
Cancer Research|March 12, 2009
CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
CSH Protocols|March 2, 2011
PCR Mutagenesis by Overlap Extension and Gene SOEAbbe N Vallejo, Robert J Pogulis, Larry R Pease
Pageof 10